KL and neoplasm: These Kla-mediated PTMs exert profound regulatory effects on multiple oncogenic processes, including tumor proliferation and metastasis, metabolic reprogramming, DNA damage repair, as well as resistance mechanisms to immunotherapy and targeted therapy [45, 147, 153–157].